Short-term incremental prednisone therapy in patients with serologically active clinically quiescent lupus nephritis: a retrospective observational study
Short-term incremental prednisone therapy is safe in reducing recurrence rates in serologically active and clinically quiescent patients with LN. Key points Incremental prednisone is safe and effective for patients with serologically active clinically quiescent LN.
Authors
- Hao-tao Chen (ORCID: https://orcid.org/0000-0001-8857-3097)
- Yong‐Zhi Xu
- Cuiwei Yao
- Jinxia Chen (ORCID: https://orcid.org/0000-0001-8264-9759)
- Huafeng Liu (ORCID: https://orcid.org/0000-0001-6547-212X)
- Ning An (ORCID: https://orcid.org/0000-0003-0450-9253)
- Wei Deng
- Le Zhang (ORCID: https://orcid.org/0009-0005-9616-496X)
Institutions
- Guangdong Medical College (CN)
Publication Details
- Journal
- European journal of medical research
- Published
- 2024-11-20
- DOI
- https://doi.org/10.1186/s40001-024-02150-6
- Citations
- 2
- Primary Topic
- Systemic Lupus Erythematosus Research
- Type
- article
- Field-Weighted Citation Impact
- 0.94